ACRS icon

Aclaris Therapeutics

104 hedge funds and large institutions have $737M invested in Aclaris Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 54 increasing their positions, 24 reducing their positions, and 12 closing their positions.

Holders
104
Holders Change
Holders Change %
0%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
12
Increased
54
Reduced
24
Closed
12
Calls
$4.24M
Puts
$354K
Net Calls
+$3.88M
Net Calls Change
+$81K
Name Holding Trade Value Shares
Change
Shares
Change %
CG
101
Cutler Group
California
$2K +$2K +100 New
LTFS
102
Ladenburg Thalmann Financial Services
Florida
$1K
PHK
103
Point72 Hong Kong
Hong Kong
$1K +$229 +11 +30%
TRCT
104
Tower Research Capital (TRC)
New York
$1K +$1K +27 New
FHAM
105
Folger Hill Asset Management
New York
-$8.04M -296,569 Closed
ACP
106
Acuta Capital Partners
California
-$2.44M -90,000 Closed
KCM
107
Kennedy Capital Management
Missouri
-$2.03M -74,962 Closed
GPCM
108
Granite Point Capital Management
Massachusetts
-$1.78M -65,680 Closed
JGC
109
J. Goldman & Co
New York
-$1.65M -60,975 Closed
SSA
110
Schonfeld Strategic Advisors
New York
-$1.09M -40,000 Closed
Renaissance Technologies
111
Renaissance Technologies
New York
-$784K -28,900 Closed
ARTA
112
A.R.T. Advisors
New York
-$640K -23,600 Closed
SCA
113
Secor Capital Advisors
New York
-$498K -18,370 Closed
HI
114
HBK Investments
Texas
-$430K -15,867 Closed
Millennium Management
115
Millennium Management
New York
-$409K -15,092 Closed